| ATCC 29236| Blautia coccoides| Blautia coccoides (Kaneuchi et al. 1976) Liu et al. 2008| Clostridium coccoides| Clostridium coccoides Kaneuchi et al. 1976 (Approved Lists 1980)| DSM 935| JCM 1395| NCTC 11035| strain CLC-1
Short-Chain Fatty Acid Production: Blautia coccoides, like many other bacteria in the gut, is involved in the fermentation of dietary fibers and complex carbohydrates. During this process, they produce short-chain fatty acids (SCFAs), such as acetate, propionate, and butyrate. SCFAs have been associated with various health benefits, including serving as an energy source for colonocytes (cells lining the colon) and contributing to the maintenance of gut barrier function.
Metabolic Health: Some studies have suggested a potential association between the abundance of Blautia species, including B. coccoides, and metabolic health. Changes in the gut microbiota composition, including alterations in Blautia abundance, have been observed in conditions such as obesity and metabolic disorders.
Immune System Modulation: The gut microbiota, including Blautia species, plays a role in educating and modulating the immune system. Certain bacteria, including those in the Blautia genus, contribute to the development and regulation of the immune response in the gastrointestinal tract.
Dietary Influence: The abundance of Blautia coccoides and related bacteria in the gut can be influenced by dietary factors. Diets rich in fiber and plant-based foods are associated with a more diverse gut microbiota, and certain Blautia species may thrive in such environments.
A lot more information is available when you are logged in and raise the display level
Other Sources for more information:
Statistics | NCBI | Data Punk | End Products Produced |
Different labs use different software to read the sample. See this post for more details.
One lab may say you have none, another may say you have a lot! - This may be solely due to the software they are using to estimate.
We deem lab specific values using values from the KM method for each specific lab to be the most reliable.
Lab | Frequency | UD-Low | UD-High | KM Low | KM High | Lab Low | Lab High | Mean | Median | Standard Deviation | Box Plot Low | Box Plot High | KM Percentile Low | KM Percentile High |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Other Labs | 0.84 | 130 | 19190 | 0 | 18581 | 5008.4 | 2313 | 6924.7 | 130 | 19190 | 0 %ile | 100 %ile | ||
biomesight | 93.5 | 290 | 14220 | 2000 | 14740 | 0 | 28918 | 9126.1 | 6170 | 10097.7 | 170 | 17310 | 11.1 %ile | 91 %ile |
thorne | 17.24 | 1 | 3 | 0 | 3 | 1.8 | 2 | 0.8 | 1 | 3 | 14.3 %ile | 71.4 %ile | ||
thryve | 0.27 | 983 | 5580 | 0 | 8142 | 3547.3 | 4079 | 2344.2 | 983 | 5580 | 20 %ile | 60 %ile | ||
ubiome | 10.65 | 0 | 20 | 2066 | 0 | 1119 | 290 | 100 | 423.2 | 0 | 614 | 0 %ile | 100 %ile |
Source of Ranges | Low Boundary | High Boundary | Low Boundary %age | High Boundary %age |
---|
Lab | Frequency Seen | Average | Standard Deviation | Sample Count | Lab Samples |
---|---|---|---|---|---|
BiomeSight | 99.798 % | 0.907 % | 1.011 % | 2959.0 | 2965 |
custom | 4.918 % | 1.484 % | 0.754 % | 3.0 | 61 |
Medivere | 100 % | 0.68 % | 0.632 % | 7.0 | 7 |
SequentiaBiotech | 22.222 % | 0.026 % | 0.018 % | 8.0 | 36 |
Thorne | 13.462 % | 0 % | 0 % | 14.0 | 104 |
Thryve | 0.288 % | 0.391 % | 0.205 % | 4.0 | 1391 |
Tiny | 100 % | 0.053 % | 0.063 % | 2.0 | 2 |
uBiome | 10.606 % | 0.029 % | 0.042 % | 84.0 | 792 |
|
And display level must be raised above public.
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Explanations/Info/Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations. Please report any to us for correction.
Copyright 2016-2024 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.